Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4467380
Max Phase: Preclinical
Molecular Formula: C33H32F3IN6O7
Molecular Weight: 808.55
Molecule Type: Unknown
Associated Items:
ID: ALA4467380
Max Phase: Preclinical
Molecular Formula: C33H32F3IN6O7
Molecular Weight: 808.55
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NCCOCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C33H32F3IN6O7/c34-21-7-6-20(29(28(21)36)40-23-8-5-18(37)17-22(23)35)30(45)42-50-14-2-11-38-12-15-49-16-13-39-24-4-1-3-19-27(24)33(48)43(32(19)47)25-9-10-26(44)41-31(25)46/h1,3-8,17,25,38-40H,2,9-16H2,(H,42,45)(H,41,44,46)
Standard InChI Key: AOVQNYCJVUDYLP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 808.55 | Molecular Weight (Monoisotopic): 808.1329 | AlogP: 3.62 | #Rotatable Bonds: 16 |
Polar Surface Area: 167.20 | Molecular Species: BASE | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.45 | CX Basic pKa: 9.40 | CX LogP: 4.91 | CX LogD: 2.93 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.06 | Np Likeness Score: -1.11 |
1. Wei J, Hu J, Wang L, Xie L, Jin MS, Chen X, Liu J, Jin J.. (2019) Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader., 62 (23): [PMID:31730343] [10.1021/acs.jmedchem.9b01528] |
2. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):